Exagen | DEFA14A: Others
Apr 26 17:10 ET
Exagen | ARS: Annual Report to Security Holders
Apr 26 09:28 ET
Exagen | 8-K: Current report
Apr 26 08:34 ET
Exagen | DEF 14A: Definitive information statements
Apr 26 08:33 ET
Exagen | 10-K: Annual report
Mar 18 09:29 ET
Exagen | 8-K: Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Mar 18 08:04 ET
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Mar 6 16:12 ET
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer ABALLI JOHN
Mar 4 16:12 ET
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Feb 22 16:20 ET
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer ABALLI JOHN
Feb 22 16:14 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(6.8%)
Feb 14 14:49 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
Feb 14 07:16 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Stonepine Capital Management, LLC(3.9%),Stonepine Capital, L.P(3.9%), etc.
Feb 13 16:42 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James L.L. Tullis(10.7%),Tullis-Dickerson Capital Focus III, L.P.(6.5%), etc.
Feb 13 06:14 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 9 17:15 ET
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Feb 8 16:09 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(5.27%)
Feb 2 15:21 ET
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-NMSIC Co-Investment Fund, L.P.(13.55%),Sun Mountain Capital Partners, L.L.C.(13.55%)
Jan 22 00:00 ET
Exagen | 8-K: Current report
Jan 8 00:00 ET
Exagen | 8-K: Current report
Dec 11, 2023 16:05 ET
No Data
No Data